Cite Filings / ARWR / 0001193125-20-007280
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
PRE 14A

Proxy Statement (Preliminary)

ARROWHEAD PHARMACEUTICALS, INC. · Filed 2020-01-14 · Acc 0001193125-20-007280

Documents 1

  • PRE 14A Proxy Statement (Preliminary) , d864868dpre14a.htm

Around this filing

  • 2023-01-20 PRE 14A Proxy Statement (Preliminary)
  • 2020-01-14 PRE 14A Proxy Statement (Preliminary)
  • 2020-01-13 3 Initial Statement of Ownership
  • 2020-01-08 4 Chief Operating Officer sold 35,613 shares at an average $60.13 ($2,141,285)
  • 2020-01-08 4 General Counsel sold 14,625 shares at an average $60.12 ($879,261)
  • 2020-01-08 4 Chief Financial Officer sold 20,000 shares at an average $60.11 ($1,202,201)
  • 2015-01-13 PRE 14A Proxy Statement (Preliminary)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d864868dpre14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…